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Case Report
Escitalopram for Psychogenic Nausea and Vomiting: 
A Report of Two Cases
Wen-Yu Hsu,1,2 Si-Sheng Huang,1,2,3* Nan-Ying Chiu1,2,4
Psychogenic nausea and vomiting is defined as vomiting without any obvious organic pathology or 
vomiting with a psychological etiology. The treatment for such a condition is a challenge in clinical practice.
The first patient was a 46-year-old married factory worker who was repeatedly hospitalized for recurring
bouts of nausea and vomiting. After consultation, she was diagnosed with major depressive disorder. The
frequency of nausea and vomiting decreased after treatment with daily doses of 10–20 mg escitalopram.
The second patient was a 37-year-old married teacher who had bouts of nausea and vomiting and was also
hospitalized repeatedly. She was diagnosed with mixed anxiety–depressive disorder. After treatment with
10 mg/day escitalopram, her episodes of nausea and vomiting decreased. Escitalopram may be an effective
treatment for psychogenic nausea and vomiting associated with depression.
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Escitalopram is a selective serotonin reuptake in-
hibitor (SSRI) that is approved for treatment of
major depressive and generalized anxiety disorders.
Other indications include social anxiety, panic,
and obsessive–compulsive disorders. Escitalopram
is a highly selective serotonin reuptake inhibitor,
and thus has few side effects related to its sero-
tonergic activity.
Nausea and vomiting are commonly seen in
internal medicine. Nausea and vomiting may have
iatrogenic, toxic, or infectious causes, or may be
due to gastrointestinal disorders, or central ner-
vous system or psychiatric conditions.1 Leibovich
has defined psychogenic nausea and vomiting as
vomiting without any obvious organic pathology
or with a psychological etiology.2 Some psychi-
atric illnesses, such as depressive, anxiety, panic,
psychotic, or obsessive–compulsive disorder, can
also produce nausea and vomiting.3
Many pharmacological agents are available for
treating psychogenic nausea and vomiting, includ-
ing tricyclic antidepressants, trazodone, and mir-
tazapine. To the best of our knowledge, the two
following cases are the first reports of the use of
escitalopram for patients with psychogenically
based nausea and vomiting.
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Case Reports
Case 1
Patient A was a 46-year-old married woman who
was brought to our emergency department for
treatment of persistent nausea and vomiting. A
review of her past medical and personal histories
showed that she had been married for 20 years.
She had worked in her husband’s factory since
they were first married. She and her husband had
adopted two children. The adopted daughter was
a college student and the son was in senior high
school. Her premorbid personality was extroverted
and optimistic, and she was described as “quick-
tempered”. Patient A developed diabetes mellitus
after using a weight-loss drug when she was 
20 years old. For the past 8 years, she had used
insulin to control her blood sugar levels. She
also had a history of hypertension and had taken
antihypertensive medication for 8 years. She was
regularly followed up at the internal medicine
outpatient clinic at our hospital.
Patient A had experienced bouts of nausea and
vomiting for 1 year, and she had been hospital-
ized five times within 2 months due to recurrent
nausea and vomiting. Peptic ulcer disease and
pancreatitis were considered, but there was no
evidence to support either diagnosis. When we
examined her, she had generalized weakness as
well as nausea and vomiting. The results of labo-
ratory studies showed: white blood cell count,
9400/μL; potassium, 3.4 mEq/L; urine ketones, 2+;
urine occult blood, 2+; and urine red blood cells,
26–30/high-power field.
When she was interviewed in the emergency
department, her anxious mood, crying, childish
attitude, and demands for an injection of sedative
for her nausea led the emergency room physician
to consult us. When we first met with patient A, we
noticed her depressive mood. She described her
worries about her daughter and son, lack of in-
terest in daily life, multiple somatic complaints,
poor appetite, low energy, poor sleep, and feelings
of worthlessness, guilt, and hopelessness. She also
had suicidal ideation. All these factors had made
it impossible for her to work in the family factory.
For all the same reasons, she had been unable to
do housework for the past 2 months. We diag-
nosed major depressive disorder, single episode,
with anxiety. Daily doses of 10 mg escitalopram
were prescribed, with long-term follow-up in our
psychiatric outpatient department.
When we treated patient A, we prescribed
10–20 mg/day escitalopram for her depression and
2 mg/day lorazepam to be taken at bedtime for
her insomnia. She also received brief supportive
psychotherapy at every psychiatric outpatient visit.
After using escitalopram for 4 weeks, her bouts of
nausea and vomiting occurred less frequently, and
were less worrisome to her. During subsequent
visits, patient A revealed that she felt stressed by
a poor relationship with her son and daughter.
Several years before, her daughter had moved out,
and until recently they had little regular contact.
Recently, her teenage son, who still lived at home,
had been impatient with her. After 7 weeks of es-
citalopram treatment, she was able to begin work-
ing in their factory again and she could also do
some housework. After 8 months of follow-up in
our outpatient service, patient A had had only 
a few episodes of nausea and vomiting and no
hospitalizations.
Case 2
Patient B was a 37-year-old married teacher who
was admitted to our gastrointestinal ward after re-
peated complaints of nausea and vomiting. Her
gastroenterologist consulted us because the patient
had frequent nausea and vomiting but no specific
physical findings related to her complaints. We re-
viewed her past medical and personal history.
Her premorbid personality was strong-minded
and dominant. She had been a senior high school
teacher for 9 years and married for 8 years. She
had her first severe nausea and vomiting episode
4 years ago, during the first trimester of pregnancy.
Her nausea and vomiting subsided after she re-
ceived therapy with Chinese traditional herbal
medicine. However, severe vomiting returned
when she gave birth. Around 18 months before
we first saw her, she was admitted to the endocrine
ward after several weeks of general weakness, easy
W.Y. Hsu, et al
64 J Formos Med Assoc | 2011 • Vol 110 • No 1
sweating, frequent hunger, and insomnia. The ini-
tial impression was that she had hyperthyroidism
(Graves’ disease). When she was followed up at
the endocrine outpatient department, propyl-
thiouracil and propranolol were prescribed. After
treatment, her thyroid function was normal.
Despite this, patient B had bouts of severe nau-
sea and vomiting for the past 5 months. She was
hospitalized on the internal medicine ward four
times and sent to the emergency department seven
times within 5 months. Her medications did not
change during that time.
The results of laboratory studies showed: mild
hypokalemia, 3.3 mEq/L; ketones in the urine;
and normal free thyroxine. There were no other
abnormal findings. Acute gastroenteritis was sus-
pected, and she was hospitalized by her internist.
After treatment with normal saline and electrolyte
supplementation, her nausea and vomiting sub-
sided within 3 days after each hospitalization.
Nearly every episode of nausea and vomiting oc-
curred near the weekend. Due to repeated hospital-
izations and her poor response to gastrointestinal
medications, the gastroenterologist consulted us.
When we interviewed her, patient B focused on
her physical problems. She denied use of alcohol
or illegal substances. She also denied having a low
mood or lack of interest during the first interview
in the internal medicine ward. She admitted having
a poor appetite, mild abdominal pain, and in-
somnia. After we established a better rapport, she
revealed that she felt increasing stress as each week-
end approached. She lived with her parents during
the week, and her parents helped care for her child
while she worked. Her husband worked in another
city. On the weekends, she lived with her husband
and his parents. During the weekend, she took care
of her child by herself and conflicts between her
and her husband increased. During visits to the
psychiatric outpatient department, she revealed
that she had dysphoric mood, anxiety, poor sleep,
somatic complaints, and low self-esteem. Mixed
anxiety–depressive disorder was diagnosed. We
prescribed 10 mg/day escitalopram, with 2 mg
lorazepam to be taken at bedtime for her insom-
nia. She received brief supportive psychotherapy at
every visit to our psychiatric outpatient service.
After 1 week of medication, she was less tense and
her sleep improved. The frequency of nausea and
vomiting decreased to twice per month.
Discussion
Both patients had repeated nausea and vomiting
without obvious organic causes and depression
was diagnosed in both cases. Treatment with es-
citalopram reduced the frequency of nausea and
vomiting in both patients. Although both patients
had taken lorazepam for insomnia, it had a limited
effect on nausea and vomiting. Lorazepam is a
short-acting benzodiazepine with a half-life < 12
hours. Therefore, its impact on nausea and anxi-
ety during the daytime was limited in our patients.
In addition, before our psychiatric intervention,
both women had been treated with benzodiaze-
pines, with no effect. Brief supportive psychother-
apy might have played a role in the successful
treatment. However, as a recent study has noted,
in the first few weeks of treatment for depression,
pharmacotherapy is superior to short-term psy-
chodynamic supportive psychotherapy.4
We believe that escitalopram played a signifi-
cant role in the successful treatment of the two
patients’ nausea and vomiting. As for the mecha-
nisms involved, the process of nausea and vomit-
ing involves various receptors, transmitters, and
neuronal pathways. The vomiting center, located in
the medulla, initiates the vomiting process.5 The
cortex, limbic system, labyrinth, chemoreceptor
trigger zone, esophagus, stomach, and small intes-
tine are involved in triggering the vomiting center.6
Depression and anxiety are related to the limbic
system, which can also affect the vomiting center.
Based on the above pathway for depression and
anxiety, there might be two explanations for the
efficacy of escitalopram for psychogenic nausea
and vomiting. First, both patients had depres-
sion and anxiety, and both had improvement 
of symptoms after treatment with escitalopram.
Improvement of anxiety or depression might result
in fewer triggering factors from the limbic system.
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Then, decreased input to the vomiting center from
the limbic system decreases the frequency of nau-
sea and vomiting. Second, the role of serotonin
in the upper gastrointestinal tract should be con-
sidered. Serotonin is a neurotransmitter in the
enteric nervous system,7 and is generally consid-
ered to be the main candidate in modulation of
motor and sensory function from the gastroin-
testinal tract. SSRIs have adverse effects on the
gastrointestinal tract, including nausea and vom-
iting, and both adverse effects are considered to
be due to stimulation of serotonin-3 receptors in
the hypothalamus, brainstem, and gastrointesti-
nal tract.8 US Food and Drug Administration ap-
proved labeling states that escitalopram has no
or very low affinity for serotonin 1–7 receptors.9,10
Therefore, escitalopram causes less nausea and
vomiting than do other SSRIs.11
In a double-blind, placebo-controlled study,
administration of citalopram significantly lowered
chemical and mechanical esophageal sensitivity.12
Escitalopram is the S-enantiomer of citalopram,
therefore, it might have the same effect on eso-
phageal sensitivity; however, this needs further
study.
As for other antidepressants, the use of tricyclic
antidepressants, trazodone, and mirtazapine for
treating psychogenic nausea and vomiting has
been reported in open-label trials and case reports
(Table).13–19
Table. Antidepressant treatment for psychogenic nausea and vomiting
Study type 
Intervention Outcome
(sample size)
Swanson Case, serial Treated with pharmacotherapy 63% (n = 29) complete relief;
et al13 patients (n = 46) and individual psychotherapy 28% (n = 13) very infrequent nausea;
7% (n = 3) nausea less than half the time
Prakash Open-label trial Amitriptyline, desipramine, 84% (n = 31) response, 51% (n = 19) 
et al14 (n = 37 with chronic nortriptyline, doxepin, imipramine complete symptom remission
nausea and vomiting)
Haggerty Case report (n = 1) Amitriptyline 150 mg/d; individual, Patients were stable without recurrence 
and Golden15 group, and family psychotherapy of vomiting
Matthew16 Case report (n = 1) Imipramine, 25 mg, thrice daily Marked improvement in her condition; 
vomiting stopped completely
Golden Case report (n = 2) (1) Amoxapine, 150–200 mg (1) Within the first 3 days of treatment, the 
et al17 frequency of the vomiting decreased. 
By the end of the first week the 
vomiting had stopped entirely
(2) Amoxapine, 150 mg (2) The patient did not have any further
episodes of nausea or vomiting after
beginning pharmacotherapy
Hsiao Case report (n = 2) (1) Trazodone, 200 mg/d; alprazolam, (1) Less nausea and vomiting, improved 
et al18 1.5 mg/day; cognitive behavioral mood and social function
psychotherapy
(2) Trazodone, 250 mg/d; (2) Vomiting gradually improved, and she 
alprazolam, 1.5 mg/d; can now do some housework and join 
cognitive behavioral therapy; in social activities
supportive psychotherapy
Lee et al19 Case report (n = 1) Mirtazapine, 30 mg/day Significantly improved and marked 
decrease in all functional dyspepsia
symptoms and an increased appetite
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Non-pharmacological treatment of psychogenic
nausea and vomiting
Non-pharmacological treatment approaches are
as important as medication in these patients.
Supportive psychotherapy, cognitive behavioral
therapy, individual psychotherapy, group psycho-
therapy, family therapy, and marital therapy should
be considered on an individual basis for such 
patients. In a randomized controlled trial, pa-
tients who had brief psychodynamic–interpersonal
psychotherapy had better outcomes than did con-
trols.20 In another randomized controlled trial, use
of flexible coping psychotherapy was an effective
intervention for treating functional dyspepsia
symptoms. Cheng et al have found that flexible
coping psychotherapy is more effective than sup-
portive psychotherapy for patients with functional
dyspepsia.21 In a randomized trial, 126 functional
dyspepsia patients were randomized to hypno-
therapy, supportive psychotherapy plus placebo
medication, or medical treatment for 16 weeks.
Compared with the other approaches, hypnother-
apy significantly improved symptoms in short-
term or long-term treatment.22
Nausea and vomiting cause discomfort, and
repeat episodes of nausea and vomiting without
an obvious organic cause are distressing to patients
and their families. Escitalopram was effective for
lessening bouts of psychogenic nausea and vom-
iting in our two patients. The pharmacological ef-
fects of escitalopram on the limbic system, its low
affinity for serotonin-3 in the upper gastrointesti-
nal tract, and its low esophageal sensitivity might
be possible mechanisms for symptom improve-
ment. We suggest that escitalopram is effective for
treating patients with psychogenic nausea and
vomiting. Larger clinical trials will be needed to
define the mechanisms of action of escitalopram
and to support its efficacy.
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